Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Adverum Biotechnologies, Inc. | advm-ex321_144.htm |
| EX-31.2 - EX-31.2 - Adverum Biotechnologies, Inc. | advm-ex312_143.htm |
| EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc. | advm-ex311_142.htm |
| EX-23.1 - EX-23.1 - Adverum Biotechnologies, Inc. | advm-ex231_146.htm |
| EX-10.40 - EX-10.40 - Adverum Biotechnologies, Inc. | advm-ex1040_748.htm |
| EX-10.39 - EX-10.39 - Adverum Biotechnologies, Inc. | advm-ex1039_747.htm |
| EX-3.1 - EX-3.1 - Adverum Biotechnologies, Inc. | advm-ex31_910.htm |
| 10-K - ADVM-10K-20161231 - Adverum Biotechnologies, Inc. | advm-10k_20161231.htm |
Exhibit 21.1
SUBSIDIARIES OF ADVERUM BIOTECHNOLOGIES, INC.
|
Name of Subsidiary |
|
Country of Incorporation |
|
Avalanche Australia PTY LTD |
|
Australia |
|
Annapurna Therapeutics, SAS |
|
France |
|
Annapurna, Inc. |
|
Pennsylvania, USA |
|
Annapurna Therapeutics, LTD |
|
Ireland |